Time

Title

Speaker

Moderator. Dr. Saad AL Kaabi & Dr. M.Tariq Butt

3:20 – 3:30

Opening ceremony

Dr. Ghalia Al Thani
Dr. Nazeeh El Dweik

3:30 – 3:50

Update in management HBV in pediatric"

Prof. Dino Hazic
(U.K)
Moderator:
Dr. Saad AL Kaabi & Dr. M.Tariq Butt

3:50 – 4:05

The Strategy For Eliminating HBV. Transmission Through Blood Transfusion In United Arab Emirates

Dr.. Amin Al amiri
(UAE)

4:05 – 4:25

The Emergence of Hepatitis B Surface Antigen Mutants and Their Impact on Diagnostic Detection.

Dr. Paul Coleman
(USA)

4:25 – 4:45

Management of Hepatocellular Carcinoma in Hepatitis Patients.

Dr. Christian Muller
(Austria)

4:45 – 4:55

Role Of CT in Predicting Spontaneous Rupture Of Hepatocellular Carcinoma: A Life threatening condition

Dr. Hassan Mahmoud Kassem (Qatar)

4:55 – 5:30

Discussion, Poster Session & Prayer Break

Moderator. Dr. Omar Aboud & Dr. Hamad Al Adba

5:30 – 5:50

Recent in treatment of HBV

Dr. Ghent

5:50 – 6:05

Liver transplantation in HBV patients

Dr. Mohamed Al Saghir
(KSA)

6:05 – 6:15

Discussion

Moderator: Dr. Nazeeh Al Dweik/Dr. Ismail Helmi

6:15 – 6:35

Co-Morbid Conditions Associated with Chronic Hepatitis C

Prof.Abdel-Rahman El-Zayadi (Egypt)

6:35 – 6:50

Impact of Hepatitis G Virus Infection on Chronic Hepatitis C Patients: Clinical, Virological and Ultra Structural Aspects

Prof.Moutaz.H. Hassanein (Egypt)

6:50 – 7:00

Cytokines in Per Portal Fibrosis in Humans Infected with Schistoma Mansoni Viral Hepatitis and its Role in Pathogenesis

Dr. Eman Abdel Rehman (Qatar)

7:00 – 7:10

Erectile Dysfunction in HCV Patients during Interferon Therapy: Is It Organic or Psychic

Dr. Moutaz Derbala
(Qatar)

7:10 – 7:30

Molecular detection and typing of HCV infection among hemodialysis patient Saudi Arabia.

Dr. Esam Azhar (KSA)

7:30 – 7:40

Management of HCV chronic infection in hemodialysis patients

Dr. Dogana Mousa
(KSA)

7:40 – 8:00

A Retrospective Study on Recurrence of Hepatitis C Genotype IV in Living Donor Liver Transplantation 4 Years Experience Introduction

Prof. Ibrahim Moustafa
(Egypt)

8:00

Discussion & Poster Session

Dinner

Time

Title

Speaker

Moderator: Hussam Soub & Dr. Sayed Shah

8:00 – 8:10

The epidemiology and trend in viral hepatitis A, B, and C among Qatari population: compared to regional and Western Countries

Dr. Abdulbari Bener (Turkey)

8:10 – 8:20

Survey of Hepatitis Markers among Donors in Qatar

Dr. Zainab O. Fawzi
(Qatar)

8:20 – 8:30

Screening of Viral Hepatitis Infections among Expatriates Population Seeking Employment in Qatar- Challenges and Recommendations

Dr. Ahmed Ismael
(Qatar)

8:30 – 8:40

Incidence of Hepatitis B Virus in the State of Qatar- An Epidemiology Overview

Dr. Mohamed RHA Al Marri (Qatar)

8:40 – 8:50

Prevalence of HCV & HBV among Patients Attending Ibn Sina Hospital in Sirt, Libya

Dr. Shaban Bagar (Libya)

8:50 – 9:00

Genotype Distribution of Hepatitis C Virus in Qataries

Dr. Ajayeb Al Marri (Qatar)

9:00 – 9.15

Hepatitis B and C infections in health care workers

Dr. Paul Schnitzler
(Germany)

Discussion & Break

Dr. Amar Al Rikabi & Dr. Ajaib Al Marri

9:40 –10:00

Challenge in diagnosis of HCV

Prof. Momena Kamel
(Egypt)

10:00 – 10:20

Current status and future trends in HCV serology

Dr. Angela Vockel
(Germany)

10:20 – 10:30

Qatar Experience In Histopathological Diagnosis Of Hepatitis

Dr. Amar Al Rikabi (Qatar)

10:30 – 10:45

Histolopathological Changes after Interferon Therapy in chronic HCV- Genotype 4 patients

Prof. Gamal Esmat (Egypt)

10:45 –10:55

Hepatocyte Apoptosis in Chronic Hepatitis C:
A prominent Feature of Disease Severity in Egyptian Patients

Dr. Sameh Fakhri
(UAE)

10:55 – 11:15

Discussion

11:15 – 11:45

Break

Moderator: Dr/ Mohamed Al Tawil/ Prof Ghent

11:45 – 12:05

Recent management for HCV non-responders

Cihan Yurdaydın (Turkey)

12:05 – 12:15

Prolonged Therapy Of Chronic HCV With Combined Low Dose Oral Interferon Plus Ribavirin

Dr. Mohie Amer (Egypt)

12:15 – 12:30

The Natural History of Untreated Symptomatic Acute Hepatitis C Infection in Egypt

Prof. Serag Zakaria
(Egypt)

12:30 – 12:45

Predictors of hepatic fibrosis in HCV

Dr.Ayman Abdo (KSA)

12.45 – 1:00

Durability of response with IFN in HBV

Cihan Yurdaydın (Turkey)

Discussion and Lunch Break

Moderator: Dr. Ghalia Al Thani And Mohamed Faleh

4:00 – 4:20

HCV in pediatric

Prof. Dino Hadzic (U.K)

4:20 – 4:35

A Comparative Study Between Pegylated Versus Conventional Interferon for the Treatment of Chronic Hepatitis C Infection in Adult Transfusion Dependent Thalassemic Patients: An Open Label, Randomized Trial

Prof. Mirmomen (Iran)

4:35 – 4:45

Discussion

4:45 – 5:00

Guidelines Discussion & Open Discussion with Experts and
Closing Ceremony

Dr. Nazeeh El Dweik
(Qatar)